Primary record
Cyclophosphamide / Hydroxydaunorubicin / Vincristine / Prednisone regimen
- 库存
- 550 克
- 纯度
- 98.1 %
化合物标识与属性
- PubChem CID
- 56842157
- SMILES
- CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C6=C(C=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C.C1CNP(=O)(OC1)N(CCCl)CCCl
- Canonical SMILES
- CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3ccc4c(c3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO.O=P1(N(CCCl)CCCl)NCCCO1
名称与同义词
- CHOP regimen
- CDOP protocol
- CHOP protocol
- ACOP protocol
- AVCP protocol
- CAUP protocol
- COPA protocol
- CVAP protocol
- VCAP protocol
- VDCP protocol
- ATSOP protocol
- CDOP regimen
- VAP-cyclo
- A COP protocol
- A-COP protocol
- VAD II protocol
- VAP-cyclo protocol
- CHOP-14 protocol
- CHOP-21 protocol
- CDOP
- CHOP
- POG protocol 9219
- RefChem:1081499
- SCHEMBL29349723
- Pediatric Oncology Group Protocol 9219
- CID:56842157
- SID:53837746
- SID:56365823
- SID:134224710
- C034080
- C034587
- C036337
- cyclophosphamide, doxorubicin, Oncovin, prednisone
- C034080000
- C034587000
- Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone regimen
- Cyclophosphamide / Daunorubicin / Prednisone / Vincristine regimen
- Cyclophosphamide / Hydroxydaunorubicin / Vincristine / Prednisone regimen
- Cyclophosphamide regimen with Daunorubicin, Prednisone and Vincristine